Advocating AI - driven Digital Pathology
aetherAI’s mission is to use state-of-the-art information technology to improve standards of healthcare and quality of human life.
Taiwan government rolls out Asia Silicon Valley Department Plan 2.0 (2021–2024) to expand AIoT applications, which is expected to encourage a digital transformation in healthcare.
AI-powered detection solutions aetherAI Endo and aetherAI LDCT
aetherAI’s annotation-free whole-slide training approach published with global recognition in leading journal Nature Communications
Partnership with Novartis Taiwan and Linkou CGMH to use AI to improve diagnosis of blood disease
Revenues triple for third year in a row, expanding into global markets
TAIPEI Prominent Enterprise Award—R&D Award, Judge’s Award
Largest digital pathology project in Taiwan for CGMH Group, Taiwan’s largest private hospital group
Implementation of digital pathology for National Taiwan University Hospital, Taiwan’s top medical center
Series A from Quanta Computer
Introduction of world’s first fully automated AI system for bone marrow differentials
The government’s Six Core Strategic Industries Program is created to transform Taiwan’s biotech and medical technology. The inclusion of information and digital technology is expected to boost smart healthcare development.
Business Startup Award by Ministry of Economic Affairs, Taiwan, ROC
Seed funding round with investment from Cathay Venture
Optimized pipelines for training DNNs on whole-slide images
Training multiple AI models with top medical centers in the US and Taiwan, including UPMC, National Taiwan University Hospital, Taipei Veterans General Hospital, and CGHM.
Meet Neo Star Demo Show Award Winner
NVIDIA GTC Inception Award Winner
Beginning of collaboration with CGMH, Chang Gung Memorial Hospital, Taiwan’s largest private hospital group
Introduction of AI medical imaging development platform
1st project: computer-aided detection of circulating tumor cells on whole slide images
Founding of aetherAI
Meet the Team
M.D., Co-founder & CEO.
Dr. Joe Yeh holds an M.D. from National Taiwan University and studied for a doctorate in pathology at the University of Southern California, where he discovered his passion for computer programming and image analysis. Inspired by the power of computer algorithms to perform rapid, accurate image analysis and the potential to improve healthcare, Dr. Yeh left academia and founded aetherAI with KJB and Steven Yeh.
Dr. Yeh has taught deep learning in medical imaging at National Taiwan University's Department of Biomedical Engineering and National Cheng Kung University’s Department of Electrical Engineering. He has co-authored several research papers published in prestigious international publications such as Nature Communications.
Co-founder and COO
Co-founder and CTO
Sean Yu, M.S.
VP of Data Science
Peichen Lin, M.D., M.S.
VP of Clinical and Regulatory Affairs
Adam Yen, M.B.A.
VP of Business Development
aetherAI is dedicated to developing solutions for AI-Powered diagnostic support. The company’s mission is to use state-of-the-art technology to elevate standards of medical imaging diagnosis and improve quality of care. Our work focuses on the digital pathology revolution and the use of AI in medical imaging and pharmaceutical and biotech companies.
TAIPEI Prominent Enterprise Award
Business Startup Award, Ministry of Economic Affairs
10 Coolest Tech Startups by Ministry of Science and Technology
100 MVP Managers, ManagerToday,
Inception Award, NVIDIA GTC
TIEC Special Award, SingularityU APAC Global Impact Challenge
Medical Devices GMP Certification
Medical Device Manufacturing License
Taiwan FDA Medical Device License